Kyowa Hakko launches postbiotic IMMUSE in Mexico

Published: 13-Sep-2023

Partnering with manufacturer Quifaest, Kyowa Hakko has celebrated the launch of its postbiotic named IMMUSE at a product launch in Mexico

Kyowa Hakko USA is expanding the global reach of its IMMUSE postbiotic with its inaugural product launch in Mexico with the pharmaceutical manufacturer Quifaest. 

Prior to this launch, IMMUSE was only available for consumer purchase in the United States, Canada, and Europe. The launch of IMMO Forte with Quifaest in the Mexican market represents a new horizon for the ingredient. 

“Consumers around the globe are looking for new opportunities to elevate their immune health to ensure that they can power through their days feeling their best,” said Karen Todd, VP of Global Brand Marketing, Kyowa Hakko USA. "We’re so excited to have partnered with the Quifaest team to give consumers throughout Mexico a novel option with our first launch in this market.” 

Consumers around the globe are looking for new opportunities to elevate their immune health to ensure that they can power through their days

- Karen Todd, VP of Global Brand Marketing, Kyowa Hakko USA

IMMUSE is Kyowa’s postbiotic that delivers a breakthrough approach to more comprehensive immune support. Over 30 published clinical studies, including 15 human trials, support IMMUSE as an immune activator. This means that the ingredient proactively supports the immune system through a novel method of action that activates plasmacytoid dendritic cells (pDCs).

The pDC, a rare type of immune cell, functions as a key leader of the immune system and has been shown to activate pivotal cells, such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support.

Like this story? Subscribe to Nutraceutical Business Review magazine for incisive analysis, the latest news and expert-written articles from the functional food and drink industries. For more information click here.

Founded in 2002, Quifaest is committed to manufacturing food supplements and pharmaceutical grade herbal medicines and remedies that feature state-of-the-art ingredients, all to bring excellence in nutrition to Mexico. 

“I am so glad to announce that IMMUSE is now available in Mexico,” Quifaest Group's CEO Marciano Mateos said. “Our corporate mission has found a perfect match with Kyowa. This is a great partnership that will promote dietary supplements that are manufactured with very high-quality ingredients supported by science.”

You may also like